Limbix is a prescription digital therapeutics platform that delivers evidence-based mental health interventions specifically designed for young people. The platform addresses the rising prevalence of anxiety and depression among adolescents by providing accessible, clinically validated treatment options through a user-friendly digital interface.
Funding
Funding not disclosed
Founders
Product
Problem
Young people are experiencing a rising prevalence of anxiety and depression. Traditional mental health interventions are often inaccessible or not specifically designed to meet the unique needs of adolescents.
Solution
Limbix is a prescription digital therapeutics platform that delivers evidence-based mental health interventions tailored for young people. The platform provides accessible, clinically validated treatment options through a user-friendly digital interface. By offering engaging and personalized content, Limbix aims to improve mental health outcomes for adolescents and young adults. The platform's digital format allows for convenient access to therapy and support, overcoming barriers such as stigma and geographical limitations. The prescription-based model ensures that users receive appropriate clinical oversight and guidance throughout their treatment journey.
Target Audience
The primary target audience is adolescents and young adults experiencing anxiety and depression, as well as clinicians seeking accessible and effective treatment options for their patients.
Features
- Evidence-based mental health interventions designed for young people
- User-friendly digital interface for easy access and engagement
- Personalized content to meet individual needs and preferences
- Prescription-based model for clinical oversight and guidance